William Reade Kem;Lynn Johnson;Robert Freedman;Ferenc Soti
发明人:
William Reade Kem,Ferenc Soti,Robert Freedman,Lynn Johnson
申请号：
US13391371
公开号：
US20120237563A1
申请日:
2010.08.18
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The subject invention pertains to controlled-release dosage forms of anabaseine compounds, such as 3-(2,4-dimethoxybenzylidene)-anabaseine (also known as DMXBA or GTS-21) or a pharmaceutically acceptable salt thereof, methods of use, and methods for producing controlled-release dosage forms.
